Discrepancies between Vaccine Documentation and Serologic Status for Diphtheria, Tetanus, and Hepatitis B in Internationally Adopted Children.

Angela Bechini, Sara Boccalini, Ilaria Rancan, Luisa Galli, Beatrice Zanella, Elena Chiappini
Author Information
  1. Angela Bechini: Department of Health Sciences, University of Florence, 50134 Florence, Italy. ORCID
  2. Sara Boccalini: Department of Health Sciences, University of Florence, 50134 Florence, Italy. ORCID
  3. Ilaria Rancan: Meyer Children's University Hospital, Department of Health Sciences, University of Florence, 50139 Florence, Italy.
  4. Luisa Galli: Meyer Children's University Hospital, Department of Health Sciences, University of Florence, 50139 Florence, Italy. ORCID
  5. Beatrice Zanella: Department of Health Sciences, University of Florence, 50134 Florence, Italy. ORCID
  6. Elena Chiappini: Meyer Children's University Hospital, Department of Health Sciences, University of Florence, 50139 Florence, Italy.

Abstract

Internationally Adopted Children (IAC) often show suboptimal immunisation coverage, but available data are discordant. Data at the first evaluation of 2073 IAC (median age: 6 years) referred to the Meyer Children's University Hospital (Florence, Italy) in 2009-2019 were analysed in order to evaluate their immunisation status against diphtheria, tetanus, and hepatitis B. Negative antibody titres were observed in 11.5% of the IAC for diphtheria, 18.6% for tetanus, and 39.0% for hepatitis B. At multivariate analysis, originating from Africa was an independent risk factor for seronegativity for the three diseases ( < 0.001), while age below four years was an independent factor associated with protective immunity, only considering hepatitis B ( < 0.001). Vaccine documentation was an additional factor independently associated with protective immunity. However, a discrepancy between documentation (indicating previous vaccinations) and serology (showing negative antibody titres) was evidenced in 3.8% of the children for diphtheria, 12.6% for tetanus, and 29.6% for hepatitis B. This finding suggests that although vaccine documentation may reflect the presence of protective antibody titres, it should not be accepted as absolute evidence of protective immunity, underlining the importance of a complete assessment of immunisation status in IAC, particularly in those originating from Africa and aged over four years.

Keywords

References

  1. Vaccines (Basel). 2020 Mar 30;8(2): [PMID: 32235670]
  2. Pediatrics. 2001 Sep;108(3):608-12 [PMID: 11533325]
  3. Vaccine. 2010 Dec 10;29(1):95-103 [PMID: 21036132]
  4. Vaccine. 2006 May 8;24(19):4138-43 [PMID: 16545505]
  5. Hum Vaccin Immunother. 2018 Feb 1;14(2):450-455 [PMID: 29106317]
  6. Pediatrics. 2019 May;143(5): [PMID: 31036671]
  7. Vaccines (Basel). 2020 Jan 28;8(1): [PMID: 32013010]
  8. Ann Ig. 2018 Sep-Oct;30(5):431-435 [PMID: 30062371]
  9. Acta Paediatr. 2018 Jan 24;: [PMID: 29364534]
  10. Clin Microbiol Rev. 2005 Jul;18(3):510-20 [PMID: 16020687]
  11. Lancet. 2005 Oct 15-21;366(9494):1379-84 [PMID: 16226616]
  12. Vaccine. 2006 Jan 30;24(5):572-7 [PMID: 16171909]
  13. Vaccine. 2019 Oct 8;37(43):6441-6446 [PMID: 31522805]
  14. Acta Clin Belg. 2017 Oct;72(5):300-305 [PMID: 27892847]
  15. Niger J Clin Pract. 2015 May-Jun;18(3):307-11 [PMID: 25772909]
  16. Acta Biomed. 2011 Dec;82(3):208-13 [PMID: 22783717]
  17. Pediatrics. 2005 Jun;115(6):e710-7 [PMID: 15930199]
  18. Arch Pediatr Adolesc Med. 2009 May;163(5):473-9 [PMID: 19414695]
  19. Adv Pediatr Infect Dis. 1999;14:147-61 [PMID: 10079853]
  20. Acta Paediatr. 2020 May;109(5):1004-1010 [PMID: 31580515]
  21. Pediatrics. 2008 Dec;122(6):1223-8 [PMID: 19047238]
  22. Lancet. 2005 Oct 15-21;366(9494):1337-8 [PMID: 16226597]
  23. Vaccines (Basel). 2020 Feb 07;8(1): [PMID: 32046202]
  24. J Virol Methods. 2019 Apr;266:7-10 [PMID: 30660606]
  25. Hum Vaccin Immunother. 2020 Apr 2;16(4):949-954 [PMID: 31634048]
  26. PLoS One. 2018 Apr 13;13(4):e0195979 [PMID: 29652945]
  27. Lancet. 2001 Dec 22-29;358(9299):2131-2 [PMID: 11784632]
  28. Pediatrics. 2001 Oct;108(4):1050-1 [PMID: 11589214]
  29. Vaccine. 2010 Nov 23;28(50):7947-55 [PMID: 20937322]
  30. Euro Surveill. 2019 Jun;24(26): [PMID: 31266589]
  31. Matern Child Health J. 2008 Sep;12(5):599-605 [PMID: 17712613]
  32. Medicine (Baltimore). 2017 Mar;96(12):e6300 [PMID: 28328809]

Grants

  1. 24151/Fondazione Cassa di Risparmio di Firenze

Word Cloud

Created with Highcharts 10.0.0BhepatitisIACdiphtheriatetanusprotectiveimmunisationyearsstatusantibodytitres6%factorimmunitydocumentationInternationallyAdoptedChildrenoriginatingAfricaindependent<0001fourassociatedVaccinechildrenvaccineoftenshowsuboptimalcoverageavailabledatadiscordantDatafirstevaluation2073medianage:6referredMeyerChildren'sUniversityHospitalFlorenceItaly2009-2019analysedorderevaluateNegativeobserved115%18390%multivariateanalysisriskseronegativitythreediseasesageconsideringadditionalindependentlyHoweverdiscrepancyindicatingpreviousvaccinationsserologyshowingnegativeevidenced38%1229findingsuggestsalthoughmayreflectpresenceacceptedabsoluteevidenceunderliningimportancecompleteassessmentparticularlyagedDiscrepanciesDocumentationSerologicStatusDiphtheriaTetanusHepatitisimmunologicalinternationallyadoptedseroprevalence

Similar Articles

Cited By